Courses | Page 4 | AUA University - 世界杯英格兰vs伊朗波胆预测

Topic

Core Curriculum Related Education

Title	Category	Credit	Event date	Price
Curso en vivo de avances globales en cáncer de próstata: el rol de las pruebas genéticas y los inhibidores de PARP (2022) - Espanol		1.00AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation	06/15/2022	$0.00	Curso Virtual CME de Cortesía!Miércoles, 15 de junio de 2022 a las 07:00 p.m. EDTAvances globales en cáncer de próstata: El Rol de las pruebas genéticas y los inhibidores de PARP es una nueva e interesante iniciativa global educativa que presenta una serie de cuatro cursos virtuales interactivos, basados en casos, ofrecidos en inglés, mandarín, portugués y español.
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Kidney cancer is not a single disease; it is made up of several different types of cancer, each with a different histology, a different clinical course, responding differently to therapy and caused by different genes. After completing this course, attendees be able to describe the different types of kidney cancer and the genes that cause each. They will learn how to identify the different types of inherited versus sporadic forms of kidney cancer.
2022世界杯32强赛程表时间		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The course director will select 6 real cases from his own practice that represent challenging cases in bladder cancer and present them to his panelists. The panelists will review the available literature and formulate a treatment plan based upon the guidelines and published literature. The course director will then present the actual patient outcome and readdress the panelists with follow-up problems and questions to illustrate the many unique aspects of dealing with these patients.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:
2022世界杯预选赛		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The course will review the statistics of underrepresented minorities in urology and why Diversity, Equity and Inclusion (DEI) initiatives are necessary for the advancement of urology. We will define racism and educate participants on the different forms of racism. We will identify current tactics to increase the number of underrepresented minorities in urology.
Diversity, Equity and Inclusion (DEI) in Urology Series (2022)				$0.00	The American Urological Association (AUA) is proposing to create a series of educational activities that aim to address Diversity, Equity and Inclusion (DEI) in Urology. The AUA recognizes that the strength of any community is rooted in diversity and is committed to leading the way in advancing DEI within urology.Diversity, Equity and Inclusion (DEI) in Urology is comprised of multiple educational formats, including a live (in-person and virtual) course, on-demand webcast and AUAUniversity podcast series.
Economics of Healthcare: Understanding Physician Compensation Webcast (2022)				$249.00	Following a general introduction to the economics of clinical practice and various practice models (e.g. private group practice, academic and non-academic health system employment, and private equity funded), the specifics of various compensation arrangements, bonuses, benefits and other aspects of total compensation will be reviewed in detail. Indirect aspects of compensation models including topics such as call, funding and use of advanced practitioners in a practice, and expense structures will also be discussed.
Educational Assessments				$0.00	What is an assessment? Why do we need them?
Establishing Your Independent Urologic Research Lab (2022)				$39.00	NEW COMPLIMENTARY COURSEFOR AUA MEMBERS!
Evolving Landscape of Androgen Deprivation Therapy in Advanced Prostate Cancer Podcast (2021)		0.50AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	为了鼓励患者持续、高质量、循证治疗，泌尿外科协会开发了一系列播客节目，旨在提高泌尿科医生护理前列腺癌、膀胱癌和肾癌患者的能力。These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Financial Toxicity as Drugs Move Earlier into Treatment Paradigm and How This Relates to Disparities in Treatment Patterns Podcast (2022)		0.50AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	The American Urological Association (AUA) is proposing to create a series of educational activities that aim to address Diversity, Equity and Inclusion (DEI) in Urology. The AUA recognizes that the strength of any community is rooted in diversity and is committed to leading the way in advancing DEI within urology.Diversity, Equity and Inclusion (DEI) in Urology is comprised of multiple educational formats, including a live (in-person and virtual) course, on-demand webcast and AUAUniversity podcast series.
Fundamentals in Urology Webcast Only (2022)				$655.00	Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast Only option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.Webcasts will be available to view on Wednesday, July 13, 2022.
前列腺癌基因检测:Clinical Implications for Early Detection and Management of Localized and Advanced Disease Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There has been a dramatic increase in our understanding of the role of genetic testing in prostate cancer over the last several years. While the clinical impact of the breast cancer gene (BRCA1/2) mutations has been well established in the setting of breast and ovarian cancer with critical implications for treatment (e.g.
前列腺癌基因检测:Understanding Clinical Implications for Early Detection, Localized Disease, & Castration Resistant Prostate...		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There has been a dramatic increase in our understanding of the role of genetic testing in prostate cancer over the last several years. While the clinical impact of BRCA1/2 mutations has been well established in the setting of breast and ovarian cancer with critical implications for treatment (e.g.
前列腺癌的全球进展:The Role of Genetic Testing and PARP Inhibitors (2022) - English		1.00AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation	04/13/2022	$0.00	Complimentary CME Virtual Course!Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors is an exciting new global educational initiative featuring a series of four interactive, case-based, live virtual courses conducted in English, Man
Hands-On Urologic Ultrasound (2022)		8.00AMA PRA Category 1 Credit™ 8.00 Non-Physician Participation	09/17/2022	$2,700.00	Only a few spots remain! Register now before the course sells out!

Pages